| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$19 ) |
| | 2024 | 2020 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | R03DA045740 | Impact of Adding Tobacco Constituents Nornicotine and Anatabine on Self-Administered Nicotine. | 001 | 2 | NIH | 12/20/2023 | -$19 |
| | 2024 | 2020 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | R03DA045740 | Impact of Adding Tobacco Constituents Nornicotine and Anatabine on Self-Administered Nicotine. | 000 | 2 | NIH | 10/26/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $100,723 ) |
| | 2023 | 2023 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 000 | 4 | FDA | 8/4/2023 | $100,723 |
| | 2023 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | R21HD093878 | Resubmission - Test of a Training Program That Uses Virtual-Reality Technology to Improve Children's Pedestrian Behaviors: A Randomized Controlled Trial | 000 | 2 | NIH | 6/20/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $97,821 ) |
| | 2022 | 2022 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 000 | 3 | FDA | 8/10/2022 | $97,821 |
|
| Issue Date FY: 2021 ( Subtotal = $90,130 ) |
| | 2021 | 2021 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 001 | 2 | FDA | 9/1/2021 | $17,813 |
| | 2021 | 2021 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 000 | 2 | FDA | 8/12/2021 | $72,317 |
| | 2021 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD006862 | Enhancing Vet-LIRN antimicrobial resistance surveillance activity through collection of AMR data for 720 and whole genome sequencing (WGS) of 300 bacterial isolates from five Canadian provinces | 000 | 1 | FDA | 7/29/2021 | $0 |
| | 2021 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | R21HD093878 | Resubmission - Test of a Training Program That Uses Virtual-Reality Technology to Improve Children's Pedestrian Behaviors: A Randomized Controlled Trial | 000 | 2 | NIH | 9/23/2021 | $0 |
| | 2021 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD006562 | Equipment grant application for purchasing of MiSeq Illumina instrument | 000 | 1 | FDA | 12/22/2020 | $0 |
| | 2021 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | | | CAN | U18FD006562 | Equipment grant application for purchasing of MiSeq Illumina instrument | 001 | 1 | FDA | 3/18/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $115,195 ) |
| | 2020 | 2020 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 000 | 1 | FDA | 9/21/2020 | $62,823 |
| | 2020 | 2020 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD007244 | Vet-LIRN antimicrobial resistance surveillance through collection of AMR data and whole genome sequencing of isolates from Canadian provinces | 001 | 1 | FDA | 9/25/2020 | $0 |
| | 2020 | 2020 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R03DA045740 | Impact of Adding Tobacco Constituents Nornicotine and Anatabine on Self-Administered Nicotine. | 001 | 2 | NIH | 8/21/2020 | $52,372 |
| | 2020 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R21HD093878 | Resubmission - Test of a Training Program That Uses Virtual-Reality Technology to Improve Children's Pedestrian Behaviors: A Randomized Controlled Trial | 000 | 2 | NIH | 8/18/2020 | $0 |
| | 2020 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R03DA045740 | Impact of Adding Tobacco Constituents Nornicotine and Anatabine on Self-Administered Nicotine. | 000 | 1 | NIH | 11/4/2019 | $0 |
| | 2020 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006862 | Enhancing Vet-LIRN antimicrobial resistance surveillance activity through collection of AMR data for 720 and whole genome sequencing (WGS) of 300 bacterial isolates from five Canadian provinces | 000 | 1 | FDA | 12/3/2019 | $0 |
| | 2020 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006862 | Enhancing Vet-LIRN antimicrobial resistance surveillance activity through collection of AMR data for 720 and whole genome sequencing (WGS) of 300 bacterial isolates from five Canadian provinces | 001 | 1 | FDA | 8/25/2020 | $0 |
| | 2020 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006562 | Equipment grant application for purchasing of MiSeq Illumina instrument | 001 | 1 | FDA | 11/21/2019 | $0 |
| | 2020 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006562 | Equipment grant application for purchasing of MiSeq Illumina instrument | 000 | 1 | FDA | 11/19/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $254,254 ) |
| | 2019 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R21HD093878 | Resubmission - Test of a Training Program That Uses Virtual-Reality Technology to Improve Children's Pedestrian Behaviors: A Randomized Controlled Trial | 000 | 2 | NIH | 9/10/2019 | $139,779 |
| | 2019 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006862 | Enhancing Vet-LIRN antimicrobial resistance surveillance activity through collection of AMR data for 720 and whole genome sequencing (WGS) of 300 bacterial isolates from five Canadian provinces | 000 | 1 | FDA | 9/5/2019 | $60,483 |
| | 2019 | 2019 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R03DA045740 | Impact of Adding Tobacco Constituents Nornicotine and Anatabine on Self-Administered Nicotine. | 000 | 1 | NIH | 9/16/2019 | $53,992 |
|
| Issue Date FY: 2018 ( Subtotal = $242,444 ) |
| | 2018 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | U18FD006562 | Equipment grant application for purchasing of MiSeq Illumina instrument | 000 | 1 | FDA | 9/11/2018 | $105,000 |
| | 2018 | 2018 | UNIVERSITY OF GUELPH | 50 STONE RD E | GUELPH | ON | N1G 2W1 | | CAN | R21HD093878 | Resubmission - Test of a Training Program That Uses Virtual-Reality Technology to Improve Children's Pedestrian Behaviors: A Randomized Controlled Trial | 000 | 1 | NIH | 9/18/2018 | $137,444 |
|
| Issue Date FY: 2011 ( Subtotal = $156,678 ) |
| | 2011 | 2011 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R21HG005811 | FACS-MABE: A METHOD TO SORT AND ENRICH THE AS-YET UNCULTURED BACTERIAL SPECIES FR | 001 | 2 | NIH | 9/20/2011 | $70,313 |
| | 2011 | 2011 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R21HG005811 | FACS-MABE: A METHOD TO SORT AND ENRICH THE AS-YET UNCULTURED BACTERIAL SPECIES FR | 000 | 2 | NIH | 7/1/2011 | $86,365 |
|
| Issue Date FY: 2010 ( Subtotal = $89,964 ) |
| | 2010 | 2010 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R21HG005811 | FACS-MABE: A METHOD TO SORT AND ENRICH THE AS-YET UNCULTURED BACTERIAL SPECIES FR | 000 | 1 | NIH | 7/30/2010 | $89,964 |
| | 2010 | 2010 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R21HG005811 | FACS-MABE: A METHOD TO SORT AND ENRICH THE AS-YET UNCULTURED BACTERIAL SPECIES FR | 001 | 1 | NIH | 9/28/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $0 ) |
| | 2009 | 2008 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R49CE000942 | RESEARCH GRANTS TO PREVENT UNINTENTIONAL INJURIES | 000 | 3 | CDC | 9/11/2009 | $0 |
|
| Issue Date FY: 2007 ( Subtotal = $238,319 ) |
| | 2007 | 2007 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R49CE000942 | RESEARCH GRANTS TO PREVENT UNINTENTIONAL INJURIES | 000 | 2 | CDC | 6/8/2007 | $238,319 |
|
| Issue Date FY: 2006 ( Subtotal = $245,922 ) |
| | 2006 | 2006 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R49CE000942 | RESEARCH GRANTS TO PREVENT UNINTENTIONAL INJURIES | 000 | 1 | CDC | 9/14/2006 | $245,718 |
| | 2006 | 2006 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R49CE000942 | RESEARCH GRANTS TO PREVENT UNINTENTIONAL INJURIES | 000 | 1 | CDC | 9/14/2006 | $204 |
|
| Issue Date FY: 2000 ( Subtotal = $38,044 ) |
| | 2000 | 2000 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R01AA012077 | HEPATIC OXYGENATION CHANGES IN CHRONIC ETHANOL TREATMENT | 000 | 2 | NIH | 4/21/2000 | $38,044 |
|
| Issue Date FY: 1999 ( Subtotal = $42,238 ) |
| | 1999 | 1999 | UNIVERSITY OF GUELPH | *** | GULEPH | | | | CAN | R01AA012077 | HEPATIC OXYGENATION CHANGES IN CHRONIC ETHANOL TREATMENT | 000 | 1 | NIH | 4/26/1999 | $42,238 |
|
|
